ヒト化抗ヒトＰＤ－１抗体 - OSE Immunotherapeutics

Title:

ヒト化抗ヒトＰＤ－１抗体

Document Type and Number:

Japanese Patent JP7404423

Kind Code:

B2

Abstract:

Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectious disease.

Inventors:

Nikola Poirier
Caroline Marie
Virginie Tepnier
Oroll Morero
Sabrina Pangam

Application Number:

JP2022040264A

Publication Date:

December 25, 2023

Filing Date:

March 15, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

OSE Immunotherapeutics

International Classes:

C12N15/13; A61K35/12; A61K35/76; A61K39/395; A61K45/00; A61K48/00; A61P31/00; A61P31/12; A61P31/14; A61P31/16; A61P31/20; A61P31/22; A61P35/00; A61P37/04; A61P43/00; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08

Domestic Patent References:

JP2016523516A
JP2018529359A
JP2018502044A

Other References:

Immunity, 2013, 39(1), pp.1-10

Attorney, Agent or Firm:

Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe

Previous Patent: A method and system for a computer to advance a game based on user location information, and a progr...

Next Patent: Information processing device, information processing method, program, and information processing sy...